Radiomic signature-based nomogram to predict disease-free survival in stage II and III colon cancer

Volume: 131, Pages: 109205 - 109205
Published: Oct 1, 2020
Abstract
Purpose To develop a radiomic nomogram to predict disease-free survival (DFS) in patients with colon cancer. Methods We retrospectively identified 302 patients with stage III colon cancer and 269 patients with stage II colon cancer who had undergone multidetector computed tomography (MDCT) and radical resection between January 2009 and December 2015. Patients were divided into a training cohort (n = 322) and an external validation cohort (n =...
Paper Details
Title
Radiomic signature-based nomogram to predict disease-free survival in stage II and III colon cancer
Published Date
Oct 1, 2020
Volume
131
Pages
109205 - 109205
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.